Endologix Announces 2005 Third Quarter Financial Results Conference Call
October 20 2005 - 2:28PM
Business Wire
Endologix, Inc. (NASDAQ:ELGX), the developer of the Powerlink(R)
System for the minimally invasive treatment of abdominal aortic
aneurysms (AAA), today announced that the Company will hold a
conference call to discuss 2005 third quarter financial results on
Friday, October 28, 2005, at 11:00 a.m. Eastern Time (8:00 a.m.
Pacific Time). Individuals interested in listening to the live
conference call may do so by dialing (888) 463-4487 toll free
within the U.S. and Canada, or (706) 634-5615 for international
callers. A telephone replay of the conference call will be
available for 48 hours beginning October 28 within two hours after
the conclusion of the call, by dialing (800) 642-1687 domestically
or (706) 645-9291 internationally, and entering reservation number
1525278. The conference call can be heard live via audio webcast at
the Company's Web site: www.endologix.com. A replay will also be
available for 90 days. About Endologix Endologix, Inc. develops and
manufactures minimally invasive treatments for vascular diseases.
Endologix's Powerlink System is an endoluminal stent graft (ELG)
for treating abdominal aortic aneurysms (AAA). AAA is a weakening
of the wall of the aorta, the largest artery in the body, resulting
in a balloon-like enlargement. Once AAA develops, it continues to
enlarge and, if left untreated, becomes increasingly susceptible to
rupture. The overall patient mortality rate for ruptured AAA is
approximately 75%, making it the thirteenth leading cause of death
in the U.S. In October 2004, Endologix received approval to market
the Powerlink in the U.S. Additional information can be found on
Endologix's Web site at www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024